Ticagrelor-based therapy for recent mild stroke or high-risk TIA
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether switching to a simpler antiplatelet medication (ticagrelor) after a mild stroke or high-risk TIA can prevent another stroke while reducing the risk of bleeding. It is for people who have not received clot-busting treatment or had a large stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Had a mild stroke within the past 24 hours, or a high-risk TIA (mini-stroke with ABCD score > 4)
- Stroke must be confirmed by CT or MRI brain scan with no large damaged area
- No known cause of stroke from the heart (like atrial fibrillation, low heart pumping function, or valve disease)
- No unusual causes like a torn artery or blood vessel inflammation
- No significant narrowing (more than 50%) of the main neck artery on the affected side
- No history of bleeding in the brain or stomach in the last 6 months, and no current blood disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding aspirin to either ticagrelor or clopidogrel (two antiplatelet medicines) can help prevent another stroke in people who recently had a minor stroke or TIA affecting a large brain artery. It is for people who started antiplatelet treatment within 24 hours of their symptoms.
This trial tests whether adding ticagrelor or cilostazol to aspirin is better than aspirin alone for preventing another stroke. It is for patients who recently had a minor stroke or a transient ischemic attack (TIA) caused by a blockage in a large artery.
This trial tests a new anti-platelet drug called Tiprogrel to prevent another stroke in people who recently had a minor stroke or a transient ischemic attack (TIA) with certain artery narrowing or plaques. It aims to see if this medicine is safe and works better than current treatments.
This study tests whether adjusting blood-thinner medication based on a blood test can better prevent another stroke in people who recently had a minor stroke or a high-risk mini-stroke. It aims to find the safest and most effective dose for each patient.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.